Findings among patients with end-stage renal disease initiating dialysis.
Patients undergoing hemodialysis typically receive intravenous iron, despite a lack of established clinical efficacy. In this randomized controlled trial, investigators randomized 2141 patients undergoing hemodialysis to either high-dose iron sucrose, administrated proactively, or low-dose iron-sucrose, administered reactively to compare the safety and efficacy of these regimens in patients undergoing hemodialysis. The primary outcome examined was 
Patients with Medicare, Medicaid more likely to use arteriovenous fistula, graft by fourth dialysis month.
Significant reduction seen in hospitalization with receipt of high-dose versus standard-dose vaccine.
A study of new dialysis patients showed that home hemodialysis was associated with a 23% decreased risk of death at 1 year compared with in-center hemodialysis.
Use of muscle relaxants was associated with a 68%, 29%, and 30% increased risk of altered mental status, falls, and fractures, respectively.
Higher percentages of women than men on hemodialysis have anemia, infections, hypertension, and diabetes, study finds.
Serum magnesium levels of 2.6 mg/dL or higher at 1 year predict a 52% decreased risk of death from any cause.
Patients who received hemodialysis 6 times per week instead of 3 showed improvements in biomarkers of mineral metabolism and left ventricular remodeling.
In the first year after starting dialysis, women have 16% increased odds of major adverse cardiovascular events compared with men.
In a study, arteriovenous fistula blood flow, diameter, and depth were the most informative parameters.
ESCOs are accountable for clinical quality outcomes and financial outcomes.
Recovery less likely in children with congenital anomalies.
Use of proton pump inhibitors among patients on hemodialysis increased their risk of hip fractures by 19%, study finds.
Researchers have identified specific hourly intradialytic RBV ranges that are associated with reduced all-cause mortality risk.
In a small study, apixaban showed promise as an alternative to warfarin in dialysis patients with calciphylaxis who require anticoagulation therapy.
1. Patient reported experience has recently been incorporated into Quality Incentive Programs for dialysis centers across the United States. Lower patient experience scores were reported in for-profit, free-standing, and large dialysis organization centers. 2. Centers with higher proportion of black and Native American patients had lower patient reported experience scores. Evidence Rating Level: 3 (Average) 
Patient and graft survival are similar for patients who were on hemodialysis and peritoneal dialysis prior to transplantation.
Restoration of iron homeostasis and normal hepcidin levels appears to play a key role in freeing hemodialysis patients from having to receive erythropoiesis-stimulating agents.
Time-averaged hemoglobin levels, not hemoglobin cycling, is associated with an increased risk of left ventricular hypertrophy in pediatric dialysis patients, a study found.
Salt intake below 6 g/day is associated with increased odds of all-cause and cardiovascular in patients on hemodialysis, Japanese study shows.
Elderly patients who start dialysis with a central venous catheter but convert to an arteriovenous fistula within the first year lower their death risk significantly.
Among US dialysis patients, cardiovascular event rates are highest in those with diabetic nephropathy and lowest among those with IgA nephropathy.
Patients on hemodialysis who achieved serum phosphate levels below 4.5 mg/dL experienced a decrease in intact fibroblast growth factor 23.
In a study, hemodialysis patients who used phosphate binders had up to a 44% decreased risk of dying from infection than those who did not use the drugs.
Researchers examined the effects of the end of public funding for the medication in Australia.
Surgical procedure can correct calcium and phosphorus abnormalities and improve coronary artery calcification, study finds.
Meta-analysis reveals a 39% decreased risk of any infection among patients on long-term dialysis who have high or normal vitamin D levels.
Study reveals 15% lower odds of arteriovenous access use at hemodialysis initiation among women vs men.
New study "adds to the evidence of obesity-associated advantages," researchers conclude.
Renal and Urology News Articles
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)